1 Market Overview
1.1 Osimertinib Introduction
1.2 Market Analysis by Type
1.2.1 40mg*30 Tablets
1.2.2 80mg*30 Tablets
1.2.3 40mg*10 Tablets
1.2.4 80mg*10 Tablets
1.3 Market Analysis by Applications
1.3.1 Locally Advanced NSCLC
1.3.2 Metastatic NSCLC
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2015-2025)
1.4.1.2 Canada Market States and Outlook (2015-2025)
1.4.1.3 Mexico Market States and Outlook (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2015-2025)
1.4.2.2 France Market States and Outlook (2015-2025)
1.4.2.3 UK Market States and Outlook (2015-2025)
1.4.2.4 Russia Market States and Outlook (2015-2025)
1.4.2.5 Italy Market States and Outlook (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2015-2025)
1.4.3.2 Japan Market States and Outlook (2015-2025)
1.4.3.3 Korea Market States and Outlook (2015-2025)
1.4.3.4 India Market States and Outlook (2015-2025)
1.4.3.5 Southeast Asia Market States and Outlook (2015-2025)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2015-2025)
1.4.4.2 Egypt Market States and Outlook (2015-2025)
1.4.4.3 Saudi Arabia Market States and Outlook (2015-2025)
1.4.4.4 South Africa Market States and Outlook (2015-2025)
1.4.4.5 Turkey Market States and Outlook (2015-2025)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Osimertinib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Osimertinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.2 Incepta Pharmaceuticals Limited
2.2.1 Business Overview
2.2.2 Osimertinib Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Incepta Pharmaceuticals Limited Osimertinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.3 Everest Pharmaceuticals
2.3.1 Business Overview
2.3.2 Osimertinib Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Everest Pharmaceuticals Osimertinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.4 Beacon Pharma
2.4.1 Business Overview
2.4.2 Osimertinib Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Beacon Pharma Osimertinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.5 Drug International
2.5.1 Business Overview
2.5.2 Osimertinib Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Drug International Osimertinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
3 Global Osimertinib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2019)
3.1 Global Osimertinib Sales and Market Share by Manufacturer (2017-2019)
3.2 Global Osimertinib Revenue and Market Share by Manufacturer (2017-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Osimertinib Manufacturer Market Share in 2019
3.3.2 Top 6 Osimertinib Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Osimertinib Market Analysis by Regions
4.1 Global Osimertinib Sales, Revenue and Market Share by Regions
4.1.1 Global Osimertinib Sales and Market Share by Regions (2015-2019)
4.1.2 Global Osimertinib Revenue and Market Share by Regions (2015-2019)
4.2 North America Osimertinib Sales and Growth Rate (2015-2019)
4.3 Europe Osimertinib Sales and Growth Rate (2015-2019)
4.4 Asia-Pacific Osimertinib Sales and Growth Rate (2015-2019)
4.5 South America Osimertinib Sales and Growth Rate (2015-2019)
4.6 Middle East and Africa Osimertinib Sales and Growth Rate (2015-2019)
5 North America Osimertinib by Country
5.1 North America Osimertinib Sales, Revenue and Market Share by Country
5.1.1 North America Osimertinib Sales and Market Share by Country (2015-2019)
5.1.2 North America Osimertinib Revenue and Market Share by Country (2015-2019)
5.2 United States Osimertinib Sales and Growth Rate (2015-2019)
5.3 Canada Osimertinib Sales and Growth Rate (2015-2019)
5.4 Mexico Osimertinib Sales and Growth Rate (2015-2019)
6 Europe Osimertinib by Country
6.1 Europe Osimertinib Sales, Revenue and Market Share by Country
6.1.1 Europe Osimertinib Sales and Market Share by Country (2015-2019)
6.1.2 Europe Osimertinib Revenue and Market Share by Country (2015-2019)
6.2 Germany Osimertinib Sales and Growth Rate (2015-2019)
6.3 UK Osimertinib Sales and Growth Rate (2015-2019)
6.4 France Osimertinib Sales and Growth Rate (2015-2019)
6.5 Russia Osimertinib Sales and Growth Rate (2015-2019)
6.6 Italy Osimertinib Sales and Growth Rate (2015-2019)
7 Asia-Pacific Osimertinib by Country
7.1 Asia-Pacific Osimertinib Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Osimertinib Sales and Market Share by Country (2015-2019)
7.1.2 Asia-Pacific Osimertinib Revenue and Market Share by Country (2015-2019)
7.2 China Osimertinib Sales and Growth Rate (2015-2019)
7.3 Japan Osimertinib Sales and Growth Rate (2015-2019)
7.4 Korea Osimertinib Sales and Growth Rate (2015-2019)
7.5 India Osimertinib Sales and Growth Rate (2015-2019)
7.6 Southeast Asia Osimertinib Sales and Growth Rate (2015-2019)
8 South America Osimertinib by Country
8.1 South America Osimertinib Sales, Revenue and Market Share by Country
8.1.1 South America Osimertinib Sales and Market Share by Country (2015-2019)
8.1.2 South America Osimertinib Revenue and Market Share by Country (2015-2019)
8.2 Brazil Osimertinib Sales and Growth Rate (2015-2019)
8.3 Argentina Osimertinib Sales and Growth Rate (2015-2019)
8.4 Colombia Osimertinib Sales and Growth Rate (2015-2019)
9 Middle East and Africa Osimertinib by Countries
9.1 Middle East and Africa Osimertinib Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Osimertinib Sales and Market Share by Country (2015-2019)
9.1.2 Middle East and Africa Osimertinib Revenue and Market Share by Country (2015-2019)
9.2 Saudi Arabia Osimertinib Sales and Growth Rate (2015-2019)
9.3 Turkey Osimertinib Sales and Growth Rate (2015-2019)
9.4 Egypt Osimertinib Sales and Growth Rate (2015-2019)
9.5 Nigeria Osimertinib Sales and Growth Rate (2015-2019)
9.6 South Africa Osimertinib Sales and Growth Rate (2015-2019)
10 Global Osimertinib Market Segment by Type
10.1 Global Osimertinib Sales, Revenue and Market Share by Type (2015-2019)
10.1.1 Global Osimertinib Sales and Market Share by Type (2015-2019)
10.1.2 Global Osimertinib Revenue and Market Share by Type (2015-2019)
10.2 40mg*30 Tablets Sales Growth and Price
10.2.1 Global 40mg*30 Tablets Sales Growth (2015-2019)
10.2.2 Global 40mg*30 Tablets Price (2015-2019)
10.3 80mg*30 Tablets Sales Growth and Price
10.3.1 Global 80mg*30 Tablets Sales Growth (2015-2019)
10.3.2 Global 80mg*30 Tablets Price (2015-2019)
10.4 40mg*10 Tablets Sales Growth and Price
10.4.1 Global 40mg*10 Tablets Sales Growth (2015-2019)
10.4.2 Global 40mg*10 Tablets Price (2015-2019)
10.5 80mg*10 Tablets Sales Growth and Price
10.5.1 Global 80mg*10 Tablets Sales Growth (2015-2019)
10.5.2 Global 80mg*10 Tablets Price (2015-2019)
11 Global Osimertinib Market Segment by Application
11.1 Global Osimertinib Sales Market Share by Application (2015-2019)
11.2 Locally Advanced NSCLC Sales Growth (2015-2019)
11.3 Metastatic NSCLC Sales Growth (2015-2019)
11.4 Other Sales Growth (2015-2019)
12 Osimertinib Market Forecast (2020-2025)
12.1 Global Osimertinib Sales, Revenue and Growth Rate (2020-2025)
12.2 Osimertinib Market Forecast by Regions (2020-2025)
12.2.1 North America Osimertinib Market Forecast (2020-2025)
12.2.2 Europe Osimertinib Market Forecast (2020-2025)
12.2.3 Asia-Pacific Osimertinib Market Forecast (2020-2025)
12.2.4 South America Osimertinib Market Forecast (2020-2025)
12.2.5 Middle East and Africa Osimertinib Market Forecast (2020-2025)
12.3 Osimertinib Market Forecast by Type (2020-2025)
12.3.1 Global Osimertinib Sales Forecast by Type (2020-2025)
12.3.2 Global Osimertinib Market Share Forecast by Type (2020-2025)
12.4 Osimertinib Market Forecast by Application (2020-2025)
12.4.1 Global Osimertinib Sales Forecast by Application (2020-2025)
12.4.2 Global Osimertinib Market Share Forecast by Application (2020-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
